Skip to main content
Equibles

BARCLAYS PLC

Position in PEPG — PepGen Inc.

CIK 312069 LONDON, X0
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,899
-$71,980 QoQ
Shares Held
4,389
-90.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 72 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. PEPG ranks #328 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in PEPG

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,899 4,389
2026-03-31 $79,879 45,130
2025-12-31 $362,716 55,717
2025-09-30 $5,340 1,156
2025-06-30 $4,111 3,704
2025-03-31 $30,970 22,043
2024-12-31 $100,105 26,413
2024-09-30 $187,852 21,971
2024-06-30 $83,758 5,248
2024-03-31 $102,944 7,003
2023-12-31 $93,323 13,724
2023-09-30 $8,270 1,628
2023-06-30 $54,765 6,126
2023-03-31 $93,620 7,655
2022-12-31 $53,988 4,038
2022-09-30 $3,686 406
2022-06-30 $4,150 418